27th Oct 2023 17:21
RNS Number : 6082R
Bellevue Healthcare Trust PLC
27 October 2023
|
|
|
| Bellevue Healthcare Trust plc | |
|
|
| Transactions in own shares | |
|
|
| Bellevue Healthcare Trust plc (the "Company") announces that today it purchased the following number of its ordinary shares of 1 penny each on the London Stock Exchange through J.P. Morgan Securities plc. |
|
|
|
| Date of purchase: | 27 October 2023 |
| Number of ordinary shares purchased: | 268,370 |
| Trading venue | LSE |
| Average price paid per share: | 123.17p |
|
|
|
| The Company intends to hold the purchased shares in treasury. |
|
|
|
| Following the above transaction, the Company holds 15,207,380 of its ordinary shares in treasury and has 541,207,850 ordinary shares in issue (excluding treasury shares). |
|
|
|
| The Company's LEI is: 213800HQ3J3H9YF2UI82 |
|
|
|
|
| Enquiries: | |
| Bellevue Asset Management (UK) Ltd. | |
| Mark Ghahramani |
|
| Telephone: +44 (0) 203 326 2981 |
|
|
|
|
| J.P. Morgan Cazenove | |
| James Bouverat (Sales) |
|
| Telephone: +44 (0) 207 134 2224 |
|
|
|
|
| Apex Listed Companies Services (UK) Limited | |
| Sinead Van Duuren |
|
| Telephone: +44 (0)20 3327 9720 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy.
END
POSFLFFRIILDFIV
Related Shares:
Bellevue Health
